- Global Pharma News & Resources

Sepsis Diagnostics Market is Expected to Grow at an Ambitious CAGR of 9.3% between 2023 to 2032 | insightSLICE

The size of the global market for Sepsis Diagnostics was predicted to reach US$ 605 million in 2021 and to increase at a CAGR of 9.3% between 2023 and 2032.

The World Health Organization describes sepsis as an organ malfunction brought on by an improperly controlled host response to infections. It is brought on by the immune system’s production of chemicals as it battles pathogens.

The two main causes driving the increase in sepsis globally are the prevalence of infectious illnesses and the growing elderly population. Sepsis is most likely to develop in people with autoimmune illnesses, kidney diseases, liver cirrhosis, cancer, HIV/AIDS, newborns, pregnant women, and hospitalized patients.

Access the sample report:

Global Sepsis Diagnostics Market Key Segments:

By Technology

  • Molecular Diagnostics
  • Microbiology
  • Immunoassay
  • Other technologies

By Product

  • Instruments
  • Assays and Reagents
  • Other products

By Diagnostic Methods

  • Conventional
  • Point of Care
  • By Pathogen
  • Bacterial Sepsis
  • Fungal Sepsis
  • Other pathogens

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

The key players of the Global Sepsis Diagnostics Market are:

Major companies present in the Global Sepsis Diagnostics Market are bioMérieux SA, Bruker Corporation, Cerner Corporation, Danaher Corporation, Epic Systems Corporation, Amara Health Analytics, Becton, Dickinson and Company, McKesson Corporation, GE Healthcare, Koninklijke Philips N.V., Luminex Corporation, Wolters Kluwer N.V., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Roche Diagnostics.

Read more about the report inclusions:

Driving factors for the growth of Global Sepsis Diagnostics Market

The creation of better infection prevention and control (IPC) programs, the implementation of efficient hygiene practices, and the provision of well-equipped medical facilities are the main concerns of government authorities worldwide.

These elements are influencing the use of Sepsis Diagnostics tools and techniques for early sepsis detection. During the forecast period, it is anticipated that the global market for sepsis diagnostics will expand significantly.

Affordable and highly accurate blood culture media diagnostics will fuel the global market for sepsis diagnostics:

Based on product type, technology, pathogen type, testing type, and geography, the sepsis diagnostics market is divided into submarkets. The devices, blood culture media, assay kits and reagents, and others categories make up the global market for sepsis diagnostics.

The segment that provided the highest share of the global market for sepsis diagnostics was blood culture media, and it is predicted that this segment will continue to dominate over the projected period.

Bold culture media-based diagnostics’ excellent accuracy and low cost have boosted their use, and this is expected to have a substantial impact on the growth of the global market during the forecast period.

Related reports:

Global Knee Replacement Implants Market:

Global Asparaginase Market:

Regional performance of Sepsis Diagnostics Market

The global market for sepsis diagnostics is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South America based on geography.

Due to increased emphasis on the development of cutting-edge medical diagnostic and analytical equipment, an increase in the prevalence of infectious diseases, and an increase in the number of patients with cancer and kidney disease, North America accounted for the largest share of the global market for sepsis diagnostics.

Strong healthcare insurance coverage and the presence of international producers of analytical equipment are likely to play major roles in shaping the North American market for sepsis diagnostics.

A large portion of the worldwide Sepsis Diagnostics market is expected to come from Europe because of the region’s growing elderly population and rising incidence of infectious diseases.

Due to rising investments in the production of healthcare equipment in China, India, and Southeast Asia, the Asia Pacific region is anticipated to experience the fastest growth during the forecast period.

Demand for microbiology-based septic diagnostics will increase due to their high accuracy and speed of detection:

The global market for sepsis diagnostics is divided into four categories based on technology: microbiology, molecular diagnostics, immunoassays, and flow cytometry. Due to its high-precision quantitative microbe detection and identification capabilities, microbiology held the greatest market share for sepsis diagnostics in 2019.

Due to increased investment in the development of more advanced diagnostic tools, it is projected that this technology will be the most extensively used during the forecast period.

Due to rising usage driven by the high accuracy, quick turnaround, and high dependability offered by molecular diagnostics, it is predicted that this segment would experience the quickest growth during the projection period.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 14-Nov-2022